Genevieve Hansen
President bij Vet Therapeutics, Inc.
Profiel
Genevieve Hansen is currently the Director at Vetica Labs, Inc. and the President & Chief Scientific Officer at Vet Therapeutics, Inc. She previously worked as the Director-Protein Therapeutics at Diversa Corp.
and as the Vice President-Research at Lpath, Inc. Hansen received her graduate and doctorate degrees from Université Paris 1 Panthéon-Sorbonne.
Actieve functies van Genevieve Hansen
Bedrijven | Functie | Begin |
---|---|---|
Vet Therapeutics, Inc.
Vet Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Part of Elanco Animal Health, Inc., Vet Therapeutics, Inc. develops antibodies and pharmaceutical products for animals. The company is based in Del Mar, CA. Vet Therapeutics was acquired by Aratana Therapeutics, Inc., part of Elanco Animal Health, Inc. from July 19, 2019 on October 16, 2013 for $55.29 million. | President | - |
Vetica Labs, Inc.
Vetica Labs, Inc. Miscellaneous Commercial ServicesCommercial Services Vetica Labs, Inc. engages in other industry group. The company is headquartered in San Diego, CA. | Directeur/Bestuurslid | - |
Eerdere bekende functies van Genevieve Hansen
Bedrijven | Functie | Einde |
---|---|---|
Diversa Corp.
Diversa Corp. Miscellaneous Commercial ServicesCommercial Services Diversa searches high and low for DNA. In its quest to develop new enzymes and other active biological compounds, the biotechnology company collects and catalogs the DNA of organisms in diverse environments (from manure piles to tropical islands). A variety of manufacturers license these compounds from the firm to develop or improve their products, which include detergents, oils, animal feeds, and pharmaceuticals. Diversa's products include enzymes for the oil and gas industry | Corporate Officer/Principal | - |
Lpath, Inc.
Lpath, Inc. BiotechnologyHealth Technology Lpath, Inc. operates as a biotechnology company, which focuses on the discovery and development of lipidomic-based therapeutic antibodies, an emerging field of medical science that targets bioactive signaling lipids to treat a wide range of human diseases. It develops three drug candidates, each of them into clinical trials, and built evidence to support their approach of targeting bioactive lipids to treat a wide range of diseases. The company was founded by Roger Allen Sabbadini in September 1997 and is headquartered in San Diego, CA. | Hoofd Techniek/Wetenschap/O&O | - |
Opleiding van Genevieve Hansen
Université Paris 1 Panthéon-Sorbonne | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Bedrijven in privébezit | 4 |
---|---|
Lpath, Inc.
Lpath, Inc. BiotechnologyHealth Technology Lpath, Inc. operates as a biotechnology company, which focuses on the discovery and development of lipidomic-based therapeutic antibodies, an emerging field of medical science that targets bioactive signaling lipids to treat a wide range of human diseases. It develops three drug candidates, each of them into clinical trials, and built evidence to support their approach of targeting bioactive lipids to treat a wide range of diseases. The company was founded by Roger Allen Sabbadini in September 1997 and is headquartered in San Diego, CA. | Health Technology |
Diversa Corp.
Diversa Corp. Miscellaneous Commercial ServicesCommercial Services Diversa searches high and low for DNA. In its quest to develop new enzymes and other active biological compounds, the biotechnology company collects and catalogs the DNA of organisms in diverse environments (from manure piles to tropical islands). A variety of manufacturers license these compounds from the firm to develop or improve their products, which include detergents, oils, animal feeds, and pharmaceuticals. Diversa's products include enzymes for the oil and gas industry | Commercial Services |
Vet Therapeutics, Inc.
Vet Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Part of Elanco Animal Health, Inc., Vet Therapeutics, Inc. develops antibodies and pharmaceutical products for animals. The company is based in Del Mar, CA. Vet Therapeutics was acquired by Aratana Therapeutics, Inc., part of Elanco Animal Health, Inc. from July 19, 2019 on October 16, 2013 for $55.29 million. | Health Technology |
Vetica Labs, Inc.
Vetica Labs, Inc. Miscellaneous Commercial ServicesCommercial Services Vetica Labs, Inc. engages in other industry group. The company is headquartered in San Diego, CA. | Commercial Services |